This summer, we have interns across various functions at Glooko who are working in administrative and technical positions. Through their rewarding roles, they’re making an impact at our digital health company and helping us better our connected care technologies that improve the lives of people with diabetes and related chronic conditions.
Meet our summer interns and hear about their experiences at Glooko.
SUMMER INTERNS
Based in California, Salvatore Colli, a supply chain major and senior at Rutgers University-New Brunswick, is working on the corporate finance team on projects aligned with sales. He’s using his knowledge to help guide global data and reporting projects around contracts, lead and accounts within Salesforce. He’s found that Glooko has helped prepare him for his future career in a variety of ways, including perfecting multitasking, getting a better grasp of industry software platforms and learning how to better communicate and be organized. His favorite part of interning has been connecting with his colleagues, who are always insightful, professional and have a sense of humor.
Hailing from Connecticut, Jess Innes, a senior at Southern New Hampshire University, is working on our cybersecurity team. Her projects this summer have included audits, policy revisions and security alerts. Through her work, she believes Glooko is helping prepare her for her future career in cybersecurity. She’s found her team to be very enjoyable while working remotely and getting closer to completing her major in cybersecurity.
Jacob Liclican, a recent graduate from University of San Francisco with a major in marketing, joined our human resources team for the summer. He’s working meticulously on maintaining HR Information Systems (HRIS) records and learning more about databases each day. While Glooko has been teaching him the responsibilities and tasks associated within various departments to prepare him for his future career, he’s also had the opportunity to meet many of his colleagues in-person and virtually who he’s found to be very welcoming and supportive.
Tran Nguyen, a Connecticut-based senior at Southern New Hampshire University majoring in information technology, is spending her summer on our IT operations team. During her experience, she has been able to gain working knowledge of various softwares and processes, audits and policy revisions, while managing multiple help desk tickets from employees. She found her tasks this summer to be very interesting and her teammates to be quite helpful.
In our product management department, Lukas Nykaza, a student at Mahomet-Seymour High School in Illinois, is helping document the activation workflows of the recently redesigned Glooko® Mobile App. At our connected care company this summer, he’s learning if product and data management could be a future career. He’s enjoying the flexibility that Glooko provides to their interns and the opportunity to gain knowledge that he will be able to put to future use.
We’re thankful for all the contributions of our interns this summer!
If you’re planning to attend the Association of Diabetes Care & Education Specialists’ ADCES23 in Houston, Team Glooko wants to meet you at booth #1101 to share the latest updates to our digital health technologies.
Some of the exciting activities that you can expect from us at the meeting:
Ask An Expert: Our booth will host experienced clinicians who will share how their clinics and patients are benefitting from Glooko’s connected care platforms and achieving better health outcomes. Experts at these informal sessions include:
Gary Scheiner, MS, CDCES, Integrated Diabetes Services (Friday: 9 to 10 a.m.; Saturday: 11:30 a.m. to 12:30 p.m.) He will cover data analysis and interpretation for a variety of devices, including CGMs, insulin pumps and AID systems. Gary will walk through the various Glooko reports he relies on for different patients and the insights they provide.
Susan Weiner, RDN, CDCES, Susan Weiner Nutrition (Friday: 11:30 a.m. to 12:30 p.m.; Saturday: 9 to 10 a.m.) She will review how best to support patients in their self-care by leveraging and incorporating Glooko into their daily lives. She’ll also review various functionalities within the Glooko Mobile App and what she likes most about them from a patient engagement and user experience standpoint.
Allison Nimlos, LMFT, CDCES, Greater Than Counseling & Coaching (Saturday: 2:30 to 3:30 p.m.) She will focus on the psychosocial aspects of diabetes care management, including how data can be both empowering and anxiety inducing. Allison will discuss how she onboards newly diagnosed patients by leveraging the app’s different data visualization tools to best support the patient’s mental well-being and desired behavioral changes.
Bridget Wood, RD, LD, CDCES, Glooko (Friday: 10 to 11:30 a.m.; Sunday: 9 to 11 a.m.) She will discuss how she uses Glooko as a person living with Type I diabetes. Bridget will also share how to enhance a virtual diabetes coaching practice using the health data in the Glooko Mobile App from both the provider and patient experiences.
Food Tracker: People with diabetes can use the innovative food tracker feature of the Glooko® Mobile App to easily log their food intake, view their food data alongside data from compatible diabetes and health monitoring devices, medications and insulin, and keep a historical account of how food affects their chronic condition.
Be sure to also check out our blog series from Glooko’s very own experts.
At our booth, we hosted “Ask an Expert” where leading clinicians, including University of Missouri-Kansas City School of Medicine’s Mark Clements, MD PhD CPI FAAP, Cleveland Clinic’s Dr. M. Cecilia Lansang, Rady Children’s Hospital’s Dr. Carla Demeterco-Berggren and Integrated Diabetes Services’ Gary Scheiner, shared how their clinics and patients benefit from the Glooko connected care platforms. The expert clinicians also discussed Glooko’s EHR integration, patient engagement, remote care and population health capabilities with attendees.
On the tradeshow floor, our team talked with some users of our connected care platforms to hear how Glooko has positively impacted their clinics. Here’s what they said:
We were also a proud sponsor of the sold-out Summer 2023 DiabetesMine D-Data ExChange, where we held live demos of Glooko. The event was packed with informative and inspiring discussions on the latest developments in diabetes technology.
We look forward to showcasing our latest digital health innovations next year at ADA 2024 in Orlando!
The modern look and feel of the Home screen allows for quick access to the user’s most used actions, including seeing glucose trends, logging medication, and tracking food and exercise.
For new mobile app users getting started with Glooko, we’ve simplified the onboarding process and customized it to fit individual goals.
From easily connecting to their clinics and sharing reports with their care team to using the Quick Add slider to conveniently add food, insulin and exercise, the free Glooko Mobile App, available in the App Store and Google Play Store, goes where people with diabetes go.
Wondering what went into the redesign of our digital health app? We sat down with some of the Glooko team members, including Director of Product Design Amanda Martin, Product Designer Ben Stone and Product Manager Chase Sutton, who worked behind-the-scenes to learn more about the process.
What were the goals and motivation behind the Glooko Home screen’s new look? How did you decide what features to highlight in the Home screen?
While we always take into account feedback from our users, our team performed extensive research and interviews to see what opportunities existed for changes in the app that would result in the greatest improvements. Through this, we landed on focusing our efforts mostly on the Home screen, the onboarding process for new users, and modernizing the user experience.
In this high-impact space, we reimagined how to display insights for users through side-by-side and detailed charts and graphs with all the pertinent data, including its sources, in one place. We added Quick Add buttons for easily tracking food, insulin, medication and other actions important to people with diabetes.
Through our interviews, we learned that users like to feel connected to their doctors and care teams and view that as a major benefit of Glooko. We wanted our users to have a direct link to them, so we added to the Home screen an easy way to reach and share data with them.
We also learned that we needed to improve the onboarding experience by making it quicker to get started and sync diabetes devices. This process was a hurdle for users in the past and we sought to simplify it in the redesign. There’s now a space on the Home screen for new users who are looking to get started with Glooko.
What are some of the main takeaways from the redesign of the Glooko Mobile App? How will this help current and new users?
For both current and new users of Glooko, the updated navigation on the Home screen helps users access key features more efficiently as the older version had many features tucked away and hard to discover. We put popular features, like food logging and sharing data with care teams, front and center on the Home screen—all available with one scroll and featuring the latest synced data.
For new users, we really wanted to give them an easy onboarding experience. We learned that the earlier version of the Glooko app’s onboarding was somewhat complicated and could be viewed as a turn off for people just joining and looking to take full advantage of our digital health app.
The reimagined onboarding is guided and shows new users what to do in a very organized, “bite-sized” way that allows them to easily complete it at their own pace.
What’s the new onboarding process like? Is it easier and does it have less steps for new users?
We learned through our interviews that the onboarding process definitely needed an overhaul. Users would go to the first step of syncing their device and then never went any further with the process as they found it too difficult. Our takeaway was that we needed to get new users to the Home screen right away.
In the new process, users now start on the Home screen and can complete the onboarding tracker, which includes syncing their device, tracking their insulin and completing their Glooko profile, in any order and timeframe. Users now get to experience all the features of Glooko right out of the gate!
How did you take feedback from people living with diabetes when making these changes that improve the experience of the Glooko Mobile App?
Connecting with users and hearing from them is incredibly important to our design process.
We have a human-centered design team, so it was integral that we talked to actual Glooko users to hear their feedback. We took what we learned and brought sketches and concepts for improving the Glooko Mobile App back to them. It’s a cycle that we go through all the time, but one that we really valued in this project.
Our team had some great conversations during this process with users who synced once to those who were very active in the app and constantly logging food. Each user group who provided us with feedback helped inform our decisions in the redesign.
We also used insights from data in the app to verify our theories around user engagement during these interviews.
What’s some of the feedback you’ve received from test users on the new look?
They’ve all been very excited about the improvements to the Glooko Mobile App.
The simplified, consistent and clean approach to the new experience will continue to resonate with our users—new and existing.
What other changes will be coming in the future to the Glooko Mobile App?
We have an ambitious and exciting roadmap for the mobile app, and much of it is focused on data.
We want users to better understand their overall health, so we’re looking to develop innovative and detailed charts and graphs to enable the next-generation of diabetes insights. These new data insights will give people with diabetes and their care teams the ability to make smarter decisions to improve their health.
Additionally, we’ll introduce personalized nudges that will help encourage behavior change and guide users to better lifestyle decisions in the coming future.
While all these future upgrades are very exciting, we’re giving both people with diabetes and their doctors the ability to see the power of Glooko and what connected care really is in our new reimagined version today.
We hosted Dexcom, Novo Nordisk and Tandem in our stand to demonstrate how the Glooko platform works with their products for people living with diabetes and their care teams. We also joined these three industry partners in their stands to demonstrate how the Glooko connected care platform works with their digital health innovations and devices.
We announced our new partnership with Sanofi, which gives people with diabetes more choices in customizing their diabetes management by integrating the SoloSmart® cap for SoloStar® insulin pens with the Glooko connected care platform. This new integration will help improve insulin management and tracking, while supporting insulin dosing data.
Our poster presentation, “Remote Patient Monitoring and Glycemic Control Trends During the COVID-19 Pandemic,” highlighted the effectiveness of our remote care platform’s capabilities when healthcare delivery needed to rapidly shift due to stay-at-home orders, but clinicians needed to remain engaged and provide care to their patients with diabetes.
We were also a proud sponsor of the diaTribe Foundation and ATTD’s panel discussion, “Solvable Problems in Diabetes,” with leading experts around continuous glucose monitoring, time in range and associated therapeutic and data-driven interventions for people living with diabetes.
After an action-packed few days, our team is already looking forward to showcasing our latest innovations next year at ATTD 2024 in Florence.
At Glooko, we improve the health outcomes of people with diabetes and related chronic conditions through our personalized, intelligent, connected care platform. Our proven technologies make lives better by revolutionizing the connection between patients and healthcare providers, driving patient engagement and adherence via digital therapeutics, and accelerating the speed of clinical trials.
Through multiple clinical studies conducted, we’ve observed immediate and sustained improvements across multiple glycemic outcomes following remote patient monitoring (RPM). These findings show that RPM provides multiple clinical benefits and improved outcomes for people with diabetes.
Some of the highlights of our real-world data studies include:
Delivering Improved and Sustained Glycemic Control1,2,3
Use of the Glooko Mobile App Improving Glycemic Outcomes in 2 Months4
Declining Patient Outcomes 6-8 Weeks After Stopping Using Glooko5
1. Sheng T et al. Glycemic Improvements Following Mobile-Enabled Remote Patient Monitoring: A Randomized Control Study, ADA Scientific Sessions, June 2020. 2. Clements M, Duffee J and McCarther D. Remote patient monitoring for adults with type 2 diabetes. ADCES Research Sessions, August, 2020. 3. Sheng T, Parks L and Clements M. Remote patient monitoring in the real world: Immediate and long-term improvements in glycemic control. American Association of Diabetes Educators (AADE) Annual Meeting, Houston TX. August, 2019. 4. Offringa R et al. Digital diabetes management application improves glycemic outcomes in people with type 1 and type 2 diabetes. Journal of diabetes science and technology, 12(3), 701-708. 2018. 5. Sheng T et al. Mobile-Enabled Food Logging is Associated with Improved Glycemic Management in the Real World. Diabetes Technology Meeting (DTM), 2019. 6. Abad R et al. Use of mobile-enabled reminders feature is associated with improved behavioral and glycemic outcomes in the real world. American Diabetes Association (ADA), Scientific Sessions, 2019. 7. Babikian S et al. Deteriorating Glucose Control in Patients with Diabetes after Disengagement from a Mobile Health App. Diabetes Technology Meeting, Poster, 2020.
The automated insulin delivery system, which is composed of the Omnipod 5 App, the Pod and has Dexcom® G6 Continuous Glucose Monitor (CGM) System integration, received FDA clearance for use by individuals ages 2 and older with type 1 diabetes in 2022.
As the first tubeless AID system with smartphone control* in the U.S., Omnipod 5 integrates with the Dexcom G6 CGM System to automatically adjust insulin, help protect against highs and lows in glucose levels**, and simplify life for people with diabetes. The system’s innovative Pod uses SmartAdjust™ technology that continuously and automatically regulates insulin delivery based on a patient’s customized Target Glucose.
“With the many benefits provided by the Omnipod 5, we’re thrilled it’s compatible and available to Glooko users in the U.S.,” said David Conn, Glooko’s Executive Vice President of Partnerships and Alliances. “Our partnership with Insulet allowed us to be compatible from launch with this innovative new AID system designed for people looking to better manage their diabetes.”
Through our integration with Insulet, patients using the Omnipod 5 can connect their system to Glooko and upload their data from home via a cloud connection, expediting the time spent with healthcare providers. Healthcare providers can review the data uploaded and view standardized, comprehensive reports in the Glooko dashboard to help gain insights and make decisions to optimize care.
“The team at Insulet appreciates the support Glooko provided to make the launch of the Omnipod 5 possible and successful,” said Dr. Trang Ly, MBBS, FRACP, Ph.D., Senior Vice President and Medical Director, Insulet. “This System has been life-changing for so many people living with type I diabetes and we look forward to continuing to see its impact.”
Along with the Omnipod 5, the Glooko platform is also compatible with Insulet Corporation’s Omnipod DASH®.
At Glooko, we’re continuously increasing the number of devices that are compatible with our digital health platform, and over 3 million users around the globe have benefited in managing their health with our tools. We’re currently compatible with a majority of global diabetes and health monitoring devices on the market, which gives patients and their healthcare providers flexibility in managing their diabetes and related chronic conditions.
**Study in 240 people with T1D aged 6 – 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Brown et al. Diabetes Care (2021).
Study in 80 people with T1D aged 2 – 5.9 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Average time in Target Glucose range (12AM -< 6AM) from CGM in standard therapy vs. Omnipod 5 = 58.2% vs 81.0%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Median time with low blood glucose from CGM: standard therapy = 3.43% vs. 2.46%. Sherr JL, et al. Diabetes Care (2022).
Food is a critical component in the management of diabetes.
People with diabetes can use the Glooko mobile app, available in the App Store and Google Play Store, to easily log their food intake and keep a historical account of how food affects their chronic condition.
The data from daily meals can be viewed alongside data from compatible diabetes and health monitoring devices, medications and insulin to reveal trends and patterns to better understand what is affecting a person’s diabetes
Tracking food consumption in our digital health app can be handled in multiple different ways, including by searching the food database, using voice capture or scanning a barcode.
Database Search: Manually search for a generic or branded food item in the Glooko mobile app by typing in its name to track it. Learn how to use this feature…
The Glooko mobile app simplifies tracking food consumption while allowing users to explore nutrition facts, including carbohydrates, calories, fats and proteins.
Frequent users of the food tracker can also create personalized custom food entries of their favorite meals, so they don’t need to re-add portions multiple times.
“The food tracker feature in our mobile app allows users to see how the food they’re consuming each day may affect their diabetes,” said Glooko Chief Product Officer Ed Marshall. “Being able to see all the data in one place gives users the ability to understand how they’re doing and make informed decisions about their health.”
The Glooko mobile app and its food tracker feature is also constantly evolving to meet the needs of our global users.
To better support users in the U.K., France, Germany and Spain last year, we added unique regional food items that are searchable in British English, French, German and Spanish to our connected care app.
For handy ways on how to use the food tracker, follow along with healthy eating and living tips from Glooko’s resident dietitian, Bridget Wood, RD, LD, CDCES.
As we reflect on the past year, I’d like to take a moment to sincerely thank you, our customers, partners, friends and families for your continued partnership and support. While changing external market dynamics continued to present new challenges and new opportunities – what did not change was our commitment to our mission. As we look ahead to 2023 we are excited to increase our impact and to take our solutions to the next level, pushing the envelope of digital health to deliver the strongest positive patient outcomes for people with chronic conditions. We have many things to be thankful for, and several exciting new initiatives to share with you in 2023.
Wishing you a very happy & healthy holiday, and we look forward to our continued partnership in the new year.
Glooko, a leading provider of intelligent, connected care solutions and remote patient monitoring (RPM) for people with diabetes and related chronic conditions, presented positive data from two recent studies on remote patient monitoring at the 2022 IDF World Diabetes Congress.
The first study presented by Team Glooko at the Congress, Cost and Outcomes of a Diabetes Remote Patient Monitoring System: A Simulation Analysis, was the company’s inaugural study using a health economics and outcomes research (HEOR) simulation model. In a randomized controlled trial of RPM and digital therapeutics (DTx), the intervention resulted in significantly improved HbA1c in patients with type 2 diabetes (T2D). Incorporating these results into a microsimulation model of longer-term complications, mortality and costs demonstrated the potential for RPM and DTx to elicit health gains and cost savings among people with diabetes.
Team Glooko will continue to highlight the benefits of our connected care platform for diabetes and related chronic conditions at industry events in 2023.